Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
The health tech sector is on a dealmaking tear in 2026, with M&A activity on pace to shatter previous records. Companies are snapping up rivals to expand product suites, chase AI capabilities, and win bigger slices of employer spending. From mental health to revenue cycle management, consolidation is reshaping the digital health landscape.
Health tech's M&A engine is running hot in 2026. The sector logged 149 deals in Q1 alone — already on pace to exceed 2025's full-year total of 555 — with disclosed deal value hitting $22.7 billion, nearly matching all of last year's $30.3 billion. Rock Health found that Q2 2026 was the busiest M&A quarter for digital health since Q3 2021, with acquisitions accounting for 97.6% of all digital health exits in the first half of the year.
The drivers? Companies are racing to build broader platform offerings, lock in employer clients with bundled solutions, and acquire AI talent and capabilities before competitors do. Revenue cycle management is a particularly hot zone, while mental health, musculoskeletal care, and primary care are also seeing heavy consolidation. Private equity firms are fueling roughly a third of deals, drawn by profitable, growing businesses at more normalized valuations compared to the COVID-era peak.
By the Numbers:
Why it matters: This consolidation wave signals a maturing digital health market where scale, AI integration, and multi-product platforms are becoming table stakes. For healthcare providers and employers, fewer but larger vendors could mean more bundled pricing power — but also less room for best-of-breed solutions.
